2021 Volume 131 Issue 9 Pages 2051-2068
Psoriasis treatment mainly involves topical treatments, but these are often inadequate in terms of convenience and effectiveness for widespread lesions, severe cases, and intractable areas. Although topical combination formulations that minimize these problems are considered first-line therapy, a new treatment in the form of foam has become available. We evaluated calcipotriol / betamethasone dipropionate (Cal / BDP) foam considering its new mechanism of action, efficacy, safety, PROs, and usefulness as a new treatment for difficult-to-treat lesions. Based on our results, we recommend Cal / BDP gel as it is already used for the scalp and propose Cal / BDP foam as a promising new topical treatment option for the body and intractable areas.
